At Novocure, our mission is to extend survival for patients diagnosed with some of the most aggressive forms of cancer through the development of Tumor Treating Fields therapy. This quarter, we grew ...
It was about our premium positioning, which drove further expansion in our gross profit margin to 61.5% and our adjusted EBITDA margin to 18.2%. For example, fans saw Iga Swiatec win an incredible ...
NEW YORK, NY / ACCESS Newswire / December 23, 2025 / For much of the modern gold trade, trust has been delegated to individual companies. Refiners certified their suppliers. Traders vouched for ...